Israel

Fourth Dose of Pfizer Vaccine vs Omicron — Real-world data show less infection and severity, but long-term benefit less clear

Wed, 2022-04-06 09:30 — mike kraft

Mixed Bag for Fourth Dose of Pfizer Vaccine vs Omicron Real-world data show less infection and severity, but long-term benefit less clear Molly Walker medpagetoday

Rates of confirmed Omicron-related COVID infection and severe disease were lower after a fourth dose of the Pfizer-BioNTech vaccine, according to real-world data from Israel, although protection against confirmed infection seemed short-lived.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Overview: International developments, UK, Canada, Europe, Mideast, Asia

Mon, 2022-03-28 13:31 — mike kraft

Factbox: Latest on the worldwide spread of the coronavirus * Pfizer Inc's oral COVID-19 therapy will be evaluated as a potential treatment for patients hospitalised with the illness in a major British trial, scientists said on Monday, as cases rise in some parts of the world Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview: International developments, UK, Canada, Europe, Mideast, Asia
Log in or register to post comments

Second COVID vaccine booster significantly lowers death rate-- Israeli study

Mon, 2022-03-28 09:37 — mike kraft

Second COVID vaccine booster significantly lowers death rate, Israeli study shows Senior citizens who received a second booster of the Pfizer–BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Second COVID vaccine booster significantly lowers death rate-- Israeli study
Log in or register to post comments

Pfizer/BioNTech filed for FDA authorization for fourth Covid-19 vaccine doses for people 65 and up

Fri, 2022-03-18 10:08 — mike kraft

Pfizer/BioNTech seek FDA authorization for fourth Covid-19 vaccine doses for people 65 and up Pfizer and BioNTech submitted an application to the US Food and Drug Administration for emergency use authorization of an additional booster dose of their Covid-19 vaccine for adults 65 and older who have gotten a booster dose of any of the authorized or approved vaccine, the companies said Tuesday. Amanda Sealy, Carma Hassan and Jamie Gumbrecht, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer/BioNTech filed for FDA authorization for fourth Covid-19 vaccine doses for people 65 and up
Log in or register to post comments

Moderna files with FDA for emergency use of second Covid-19 booster shot

Fri, 2022-03-18 09:57 — mike kraft

Moderna files for emergency use of second Covid-19 booster shot The company said its request covered all adults over the age of 18, including for those at higher risk due to age or comorbidities Reuters the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna files with FDA for emergency use of second Covid-19 booster shot
Log in or register to post comments

International Generic drugmakers sign on to make cheap version of Pfizer COVID pill

Thu, 2022-03-17 12:01 — mike kraft

Generic drugmakers sign on to make cheap version of Pfizer COVID pill Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday. Michael Erman Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about International Generic drugmakers sign on to make cheap version of Pfizer COVID pill
Log in or register to post comments

Omicron BA.2 COVID variant has circulated in U.S. for some time--White House

Mon, 2022-03-14 19:14 — mike kraft

White House: Omicron BA.2 COVID variant has circulated in U.S. for some time The White House said on Monday that the Omicron BA.2 sub-variant of COVID-19 had been circulating in the United States for some time, with roughly 35,000 cases at the moment, and more money was needed to help fight it. Reuters Reuters

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Omicron BA.2 COVID variant has circulated in U.S. for some time--White House
Log in or register to post comments

Will a 4th vaccine shot improve your protection?

Thu, 2022-02-24 09:36 — mike kraft

Who might benefit from a 4th shot — and who might not Some countries are moving ahead with plans to offer a fourth dose of COVID-19 vaccine. But studies are raising questions about the potential advantages of this extra booster. NPR.org

At this point, one thing about the pandemic is clear: The COVID-19 vaccines, even when followed by a booster, aren't going to stop the coronavirus — or provide long-term protection from infections.

Country / Region Tags:

General Topic Tags: